EPIRUBICIN

Clinical trials for EPIRUBICIN explained in plain language.

Never miss a new study

Get alerted when new EPIRUBICIN trials appear

Sign up with your email to follow new studies for EPIRUBICIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New chemo approach may spare sinus cancer patients from major surgery

Disease control Recruiting now

This study is for people with a rare sinus cancer called sinonasal adenoid cystic carcinoma. The treatment delivers high-dose chemotherapy directly to the tumor through a small tube in an artery, aiming to shrink it as much as possible. After three sessions, doctors check if the …

Matched conditions: EPIRUBICIN

Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

EPIRUBICIN

Get alerted when new EPIRUBICIN trials appear

New chemo approach may spare sinus cancer patients from major surgery